Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-behcet's disease
View/ Open
Access
info:eu-repo/semantics/embargoedAccessDate
2013Author
Vural, BurçakSehitoğlu, Elçin
Çavuş, Filiz
Yalçınkaya, Nazh
Haytural, Hazal
Küçükerden, Melike
Tüzün, Erdem
Metadata
Show full item recordCitation
Vural B, Sehitoglu E, Cavus F, Yalçınkaya N, Haytural H, Kuçukerden M, Ulusoy C, Ugurel E, Turan S, Bulut L, Turkoglu R, Shugaiv E, Kurtuncu M, Atakan S, Gure AO, Gul A, Eraksoy M, Akman-Demir G, Tuzun E. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease. Journal of Neuroimmunology. 2013; 263(1-2): 139-44. doi: 10.1016/j.jneuroim.2013.08.007.Abstract
Efforts for the identification of diagnostic autoantibodies for neuro-Behcet's disease (NBD) have failed. Screening of NBD patients' sera with protein macroarray identified mitochondrial carrier homolog 1 (Mtch1), an apoptosis-related protein, as a potential autoantigen. ELISA studies showed serum Mtch1 antibodies in 68 of 144 BD patients with or without neurological involvement and in 4 of 168 controls corresponding to a sensitivity of 47.2% and specificity of 97.6%. Mtch1 antibody positive NBD patients had more attacks, increased disability and lower serum nucleosome levels. Mtch1 antibody might be involved in pathogenic mechanisms of NBD rather than being a coincidental byproduct of autoinflammation.
Source
Journal of NeuroimmunologyVolume
263Issue
1-2URI
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0165572813002166https://hdl.handle.net/11446/533